GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis AS (FRA:NZM2) » Definitions » E10

Novonesis AS (FRA:NZM2) E10 : €1.58 (As of Dec. 2023)


View and export this data going back to . Start your Free Trial

What is Novonesis AS E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Novonesis AS's adjusted earnings per share data for the three months ended in Dec. 2023 was €0.337. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is €1.58 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Novonesis AS's average E10 Growth Rate was 3.10% per year. During the past 3 years, the average E10 Growth Rate was 8.70% per year. During the past 5 years, the average E10 Growth Rate was 8.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Novonesis AS was 9.60% per year. The lowest was 3.90% per year. And the median was 8.30% per year.

As of today (2024-06-10), Novonesis AS's current stock price is €56.26. Novonesis AS's E10 for the quarter that ended in Dec. 2023 was €1.58. Novonesis AS's Shiller PE Ratio of today is 35.61.

During the past 13 years, the highest Shiller PE Ratio of Novonesis AS was 55.27. The lowest was 24.09. And the median was 38.95.


Novonesis AS E10 Historical Data

The historical data trend for Novonesis AS's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis AS E10 Chart

Novonesis AS Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.16 1.23 1.34 1.52 1.58

Novonesis AS Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 1.52 1.54 1.53 1.57 1.58

Competitive Comparison of Novonesis AS's E10

For the Specialty Chemicals subindustry, Novonesis AS's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novonesis AS's Shiller PE Ratio Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis AS's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Novonesis AS's Shiller PE Ratio falls into.



Novonesis AS E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Novonesis AS's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0.337/116.7000*116.7000
=0.337

Current CPI (Dec. 2023) = 116.7000.

Novonesis AS Quarterly Data

per share eps CPI Adj_EPS
201403 0.292 99.600 0.342
201406 0.251 99.700 0.294
201409 0.273 99.700 0.320
201412 0.261 99.400 0.306
201503 0.304 100.200 0.354
201506 0.295 100.300 0.343
201509 0.323 100.200 0.376
201512 0.301 99.800 0.352
201603 0.326 100.200 0.380
201606 0.331 100.600 0.384
201609 0.333 100.200 0.388
201612 0.360 100.300 0.419
201703 0.347 101.200 0.400
201706 0.332 101.200 0.383
201709 0.371 101.800 0.425
201712 0.360 101.300 0.415
201803 0.367 101.700 0.421
201806 0.356 102.300 0.406
201809 0.370 102.400 0.422
201812 0.386 102.100 0.441
201903 0.323 102.900 0.366
201906 0.418 102.900 0.474
201909 0.299 102.900 0.339
201912 0.435 102.900 0.493
202003 0.385 103.300 0.435
202006 0.306 103.200 0.346
202009 0.340 103.500 0.383
202012 0.313 103.400 0.353
202103 0.423 104.300 0.473
202106 0.381 105.000 0.423
202109 0.405 105.800 0.447
202112 0.301 106.600 0.330
202203 0.401 109.900 0.426
202206 0.390 113.600 0.401
202209 0.556 116.400 0.557
202212 0.427 115.900 0.430
202303 0.379 117.300 0.377
202306 0.293 116.400 0.294
202309 0.452 117.400 0.449
202312 0.337 116.700 0.337

Add all the adjusted EPS together and divide 10 will get our e10.


Novonesis AS  (FRA:NZM2) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Novonesis AS's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=56.26/1.58
=35.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Novonesis AS was 55.27. The lowest was 24.09. And the median was 38.95.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Novonesis AS E10 Related Terms

Thank you for viewing the detailed overview of Novonesis AS's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Novonesis AS (FRA:NZM2) Business Description

Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novozymes is the world leader in industrial enzymes. In recent years, the company has expanded into micro-organisms, primarily for agricultural markets. The firm supplies five major industry groups: household care, food and beverages, bioenergy, agriculture and feed, and technical and pharma. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark.

Novonesis AS (FRA:NZM2) Headlines

No Headlines